Vir Biotechnology, Inc. · NASDAQ:VIR
Sawaf Aziz received 75,000 Vir Biotechnology, Inc. shares as an award (Form 4)
Traded Nov 15, 2026 · Filed Nov 16, 2026
On Nov 15, 2026, Sawaf Aziz (EVP, Chief Financial Officer) received 75,000 Vir Biotechnology, Inc. shares as an award under a trading plan, leaving 75,000 shares. Filed Nov 16, 2026 (Form 4).
- Awarded
- 75,000 shares
- Holding after
- 75,000 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 15, 2026 | Common Stock | Award | 75,000 | 75,000 | Direct |
Source
Download original · View original at SEC